SCHEMBL3591628

SCHEMBL3591628

N#Cc1c(-c2ccco2)cc(-c2cccs2)nc1OCc1ccc(C(=O)O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 4/20 0.56
▸ ADORA1 P30542 4/20 0.56
▸ ADORA2B P29275 3/20 0.56
▸ KDM4E B2RXH2 6/20 0.50
▸ POLB P06746 5/20 0.50
▸ MAPT P10636 4/20 0.50
▸ L3MBTL1 Q9Y468 3/20 0.50
▸ ATM Q13315 1/20 0.50
▸ PDE5A O76074 1/20 0.48
▸ PDE1A P54750 1/20 0.48
▸ PDE1B Q01064 1/20 0.48
▸ PDE1C Q14123 1/20 0.48
▸ TOP1 P11387 1/20 0.44
▸ ALDH1A1 P00352 4/20 0.44
▸ HPGD P15428 3/20 0.44
▸ NPSR1 Q6W5P4 2/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ SQOR Q9Y6N5 1/20 0.44
▸ KMT2A Q03164 6/20 0.43
▸ MEN1 O00255 5/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3590688 0.93 ADORA2A (0.56) ADORA2AADORA1ADORA2BKDM4EPOLB
SCHEMBL3582497 0.88 KDM4E (0.54) ADORA2AADORA1ADORA2BKDM4EPOLB
SCHEMBL3595971 0.87 ADORA2A (0.49) ADORA2AADORA1ADORA2BKDM4EPOLB
SCHEMBL3590027 0.87 KDM4E (0.49) ADORA2AADORA1ADORA2BKDM4EPOLB
SCHEMBL3585776 0.86 KDM4E (0.52) ADORA2AADORA1ADORA2BKDM4EPOLB
SCHEMBL3580685 0.86 PDE5A (0.48) ADORA2AADORA1ADORA2BKDM4EPOLB
SCHEMBL3592649 0.85 PDE5A (0.46) ADORA2AADORA1ADORA2BKDM4EPOLB
SCHEMBL3592534 0.85 POLB (0.43) ADORA2AADORA1ADORA2BKDM4EPOLB
SCHEMBL3594942 0.85 PDE5A (0.46) ADORA2AADORA1ADORA2BKDM4EPOLB
SCHEMBL3597768 0.84 ADORA2A (0.53) ADORA2AADORA1ADORA2BKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100009973-A1 Integrase Inhibitors 3 AVEXA LIMITED (AU) 2010-01-14 — — US disclosed
US-20100009973-A1 Integrase Inhibitors 3 AVEXA LIMITED (AU) 2010-01-14 — — US disclosed
US-20100009973-A1 Integrase Inhibitors 3 AVEXA LIMITED (AU) 2010-01-14 — — US disclosed
WO-2007124546-A1 INTEGRASE INHIBITORS 3 AVEXA LIMITED (AU) 2007-11-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009973-A1 Integrase Inhibitors 3 TYMP, IMPDH1, IMPDH2 ADORA2A 3605/4885ADORA1 2470/4885ADORA2B 3500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback